Epigenetic Regulator Structural Biology Service

Understanding the precise three-dimensional architecture of epigenetic regulators is fundamental to deciphering their function and druggability. These atomic blueprints are the cornerstone of modern epigenetic drug discovery. At CD BioSciences, we provide a dedicated integrated structural biology service, specifically designed to solve the unique challenges of epigenetic targets. By leveraging the complementary power of X-ray crystallography, cryo-EM, and computational modeling, we deliver the definitive, multi-scale structural insights needed to validate mechanisms and accelerate the design of novel therapeutics.

Significance of Structural Biology Research

The fundamental principle of "structure determines function" lies at the heart of modern biology and therapeutics. In the dynamic field of epigenetics, where writers, readers, erasers, and chromatin remodelers orchestrate gene expression, understanding their precise three-dimensional architecture is not merely informative—it is indispensable. Structural biology research directly translates this principle into actionable drug discovery by providing atomic-resolution blueprints of these targets. It enables the rational design of selective inhibitors, elucidates mechanisms of drug resistance, and transforms complex biological mechanisms into targetable opportunities, thereby de-risking and accelerating the entire therapeutic development pipeline.

Fig.1 Cryo-EM single particle analysis of DNA methyltransferase 1 (DNMT1). (Kikuchi A, et al., 2022)

Our Services

Building on decades of focused expertise in macromolecular structure determination, CD BioSciences offers a complete, end-to-end structural biology partnership dedicated to epigenetic drug discovery. We guide you in selecting and applying the most powerful techniques—X-ray crystallography and cryo-electron microscopy—to solve your most challenging target structures. This integrated approach delivers the definitive insights needed to validate novel mechanisms, de-risk lead optimization, and accelerate your candidates toward the clinic.

One-stop Solution for Structural Biology Analysis

We provide a comprehensive, integrated structural biology platform, dedicated to delivering definitive three-dimensional insights into epigenetic targets. Our one-stop solution combines expert guidance with unified project management, offering seamless structural determination across all major classes of epigenetic regulators.

1. Epigenetic Target Coverage

1. Specialized Analysis Services

Protein-Ligand Co-crystallization Service

Obtain definitive atomic-resolution structures of your lead compounds in complex with their epigenetic targets. This service directly enables structure-based drug design (SBDD) by revealing precise binding modes, elucidating selectivity determinants, and rationalizing structure-activity relationships (SAR) to accelerate lead optimization.

X-Ray Crystallography Service

Solve high-resolution structures for a wide range of soluble epigenetic targets, from apo-proteins and disease mutants to protein-peptide complexes. This versatile technique provides the fundamental atomic framework for target validation, mechanism of action studies, and early-stage inhibitor discovery, delivering the clarity needed for informed decision-making.

Cryo-Electron Microscopy (Cryo-EM) Service

Resolve the architecture of large, flexible, or membrane-associated epigenetic complexes—such as chromatin remodelers and full-length modifying enzymes—in their native, functional states at near-atomic resolution. This powerful technique is essential for elucidating assembly mechanisms, understanding multi-subunit interactions, and visualizing targets that are intractable to crystallization.

Workflow of Structural Biology Service

Project Consultation & Strategy Design

We begin by understanding your key scientific questions. Our experts analyze your target's properties to recommend the optimal technique (X-ray, Cryo-EM, or an integrated approach) and design a custom strategy, including construct design and sample requirements.

Sample Preparation & Quality Control

Our specialized teams execute the tailored plan, handling protein expression (using systems like insect/mammalian cells for proper folding), purification, and rigorous biophysical analysis to ensure sample homogeneity and stability—the critical foundation for success.

Data Acquisition on Advanced Platforms

Your high-quality sample enters our integrated technology platform. We utilize automated crystallization screening, state-of-the-art Cryo-EM grids preparation and imaging, and secure access to high-flux synchrotron beamlines to collect the best possible diffraction or microscopy data.

Structure Determination & Multi-Scale Analysis

Our computational biologists solve the structure using appropriate methods. Beyond delivering atomic coordinates, we perform a specialized epigenetic analysis, examining active sites, interaction interfaces, and conformational states to extract biologically and pharmacologically relevant insights.

Insight Delivery & Iterative Support

We provide a comprehensive report with actionable conclusions and high-resolution visuals. Our partnership continues with support for data interpretation and strategy for the next steps, ensuring the structural insights directly advance your drug discovery pipeline.

Application Scenarios

Diverse Applications

1. Novel Target Validation: Determine high-resolution structures to elucidate function and directly assess therapeutic potential of new epigenetic targets.
2. Mechanism of Action Studies: Visualize native complexes and map functional interfaces to uncover molecular mechanisms and identify novel sites for drug development.
3. Structure-Based Drug Design (SBDD): Accelerate lead optimization through atomic-resolution binding insights that rationally guide compound improvement.
4. Overcoming Drug Resistance: Solve mutant target structures to reveal resistance mechanisms and enable the design of next-generation inhibitors.
5. Tool Compound & Probe Development: Provide definitive structural validation to ensure the reliability and specificity of chemical probes for biological research.

Our Advantages

1. Scientific & Strategic Consultation: Our team of PhD-level scientists provides end-to-end project guidance, from initial construct design through final data interpretation, ensuring each study is strategically aligned with your research goals.
2. Integrated Multi-Technique Platform: We offer a seamless combination of X-ray crystallography, cryo-EM, and computational modeling, expertly applied based on target characteristics to deliver the most complete structural picture.
3. Proven Success with Challenging Targets: We have a demonstrated track record of solving structures for notoriously difficult epigenetic targets, including large complexes, flexible readers, and ligand-bound states.
4. Customized Partnership Model: We function as an extension of your team, providing tailored solutions, flexible project scaling, and collaborative insight rather than a standard service package.

At CD BioSciences, our integrated structural biology platform is exclusively designed to demystify the three-dimensional architecture of your most challenging epigenetic targets. We specialize in combining X-ray crystallography, cryo-electron microscopy, and computational modeling to deliver end-to-end, customized solutions that transform complex structural data into definitive pathways for epigenetic drug discovery and development. Contact us to design a tailored structural strategy that directly addresses the unique challenges of your epigenetic research project.

Reference

1. Kikuchi A, Onoda H, Yamaguchi K, et al. Structural basis for activation of DNMT1[J]. Nature communications, 2022, 13(1): 7130.